> top > docs > PubMed:17261671 > spans > 763-1079 > annotations

PubMed:17261671 / 763-1079 JSONTXT

Annnotations TAB JSON ListView MergeView

PubMed_ArguminSci

Id Subject Object Predicate Lexical cue
T4 0-316 DRI_Approach denotes The ongoing clinical use of fibrates, which activate PPARalpha, and thiazolidinediones, which activate PPARgamma, establishes these receptors as viable drug targets, whereas considerable in vitro animal model and human surrogate marker studies suggest that PPAR activation may limit inflammation and atherosclerosis.

Inflammaging

Id Subject Object Predicate Lexical cue
T5 0-316 Sentence denotes The ongoing clinical use of fibrates, which activate PPARalpha, and thiazolidinediones, which activate PPARgamma, establishes these receptors as viable drug targets, whereas considerable in vitro animal model and human surrogate marker studies suggest that PPAR activation may limit inflammation and atherosclerosis.
T5 0-316 Sentence denotes The ongoing clinical use of fibrates, which activate PPARalpha, and thiazolidinediones, which activate PPARgamma, establishes these receptors as viable drug targets, whereas considerable in vitro animal model and human surrogate marker studies suggest that PPAR activation may limit inflammation and atherosclerosis.

DisGeNET

Id Subject Object Predicate Lexical cue
T0 53-62 gene:5465 denotes PPARalpha
T1 300-315 disease:C0003850 denotes atherosclerosis
T2 53-62 gene:5465 denotes PPARalpha
T3 300-315 disease:C0004153 denotes atherosclerosis
T4 103-112 gene:5468 denotes PPARgamma
T5 300-315 disease:C0003850 denotes atherosclerosis
T6 103-112 gene:5468 denotes PPARgamma
T7 300-315 disease:C0004153 denotes atherosclerosis
T8 257-261 gene:5465 denotes PPAR
T9 300-315 disease:C0003850 denotes atherosclerosis
T10 257-261 gene:5465 denotes PPAR
T11 300-315 disease:C0004153 denotes atherosclerosis
R1 T0 T1 associated_with PPARalpha,atherosclerosis
R2 T2 T3 associated_with PPARalpha,atherosclerosis
R3 T4 T5 associated_with PPARgamma,atherosclerosis
R4 T6 T7 associated_with PPARgamma,atherosclerosis
R5 T8 T9 associated_with PPAR,atherosclerosis
R6 T10 T11 associated_with PPAR,atherosclerosis

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 300-315 HP_0002621 denotes atherosclerosis

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
17261671-4#53#62#gene5465 53-62 gene5465 denotes PPARalpha
17261671-4#103#112#gene5468 103-112 gene5468 denotes PPARgamma
17261671-4#300#315#diseaseC0003850 300-315 diseaseC0003850 denotes atherosclerosis
17261671-4#300#315#diseaseC0004153 300-315 diseaseC0004153 denotes atherosclerosis
17261671-4#300#315#diseaseC0003850 300-315 diseaseC0003850 denotes atherosclerosis
17261671-4#300#315#diseaseC0004153 300-315 diseaseC0004153 denotes atherosclerosis
53#62#gene5465300#315#diseaseC0003850 17261671-4#53#62#gene5465 17261671-4#300#315#diseaseC0003850 associated_with PPARalpha,atherosclerosis
53#62#gene5465300#315#diseaseC0004153 17261671-4#53#62#gene5465 17261671-4#300#315#diseaseC0004153 associated_with PPARalpha,atherosclerosis
53#62#gene5465300#315#diseaseC0003850 17261671-4#53#62#gene5465 17261671-4#300#315#diseaseC0003850 associated_with PPARalpha,atherosclerosis
53#62#gene5465300#315#diseaseC0004153 17261671-4#53#62#gene5465 17261671-4#300#315#diseaseC0004153 associated_with PPARalpha,atherosclerosis
103#112#gene5468300#315#diseaseC0003850 17261671-4#103#112#gene5468 17261671-4#300#315#diseaseC0003850 associated_with PPARgamma,atherosclerosis
103#112#gene5468300#315#diseaseC0004153 17261671-4#103#112#gene5468 17261671-4#300#315#diseaseC0004153 associated_with PPARgamma,atherosclerosis
103#112#gene5468300#315#diseaseC0003850 17261671-4#103#112#gene5468 17261671-4#300#315#diseaseC0003850 associated_with PPARgamma,atherosclerosis
103#112#gene5468300#315#diseaseC0004153 17261671-4#103#112#gene5468 17261671-4#300#315#diseaseC0004153 associated_with PPARgamma,atherosclerosis

DisGeNet-2017-sample

Id Subject Object Predicate Lexical cue
T1817 53-62 gene:5465 denotes PPARalpha
T1818 300-315 disease:C0003850 denotes atherosclerosis
T1819 103-112 gene:5468 denotes PPARgamma
R1 T1817 T1818 associated_with PPARalpha,atherosclerosis
R2 T1817 T1818 associated_with PPARalpha,atherosclerosis
R3 T1819 T1818 associated_with PPARgamma,atherosclerosis
R4 T1819 T1818 associated_with PPARgamma,atherosclerosis

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T5 0-316 Sentence denotes The ongoing clinical use of fibrates, which activate PPARalpha, and thiazolidinediones, which activate PPARgamma, establishes these receptors as viable drug targets, whereas considerable in vitro animal model and human surrogate marker studies suggest that PPAR activation may limit inflammation and atherosclerosis.
T5 0-316 Sentence denotes The ongoing clinical use of fibrates, which activate PPARalpha, and thiazolidinediones, which activate PPARgamma, establishes these receptors as viable drug targets, whereas considerable in vitro animal model and human surrogate marker studies suggest that PPAR activation may limit inflammation and atherosclerosis.